Bob Belaski

Bob Belaski is a National Account Director with over 25 years of experience in the pharmaceutical industry, specializing in orphan diseases, oncology, bi-specifics, CAR-T, immunology, and cell and gene therapy. They currently serve as the Director of National Accounts at Precigen and have held pivotal roles at notable companies including Johnson & Johnson Innovative Medicine and Actelion Pharmaceuticals. Bob's expertise extends to payer negotiations and managing care strategies, with a proven track record in enhancing patient access and reimbursement processes. They are pursuing a Bachelor of Science in Business Administration at Bloomsburg University of Pennsylvania.